Pombiliti 105 mg lyophilized powder for injection Images
Generic Name: cipaglucosidase alfa
This medication has been identified as Pombiliti 105 mg lyophilized powder for injection. It is supplied by Amicus Therapeutics, Inc.
Pombiliti is used in the treatment of Pompe Disease and belongs to the drug class lysosomal enzymes. Pombiliti 105 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Pombiliti
- Generic Name
- cipaglucosidase alfa
- Strength
- 105 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Lysosomal enzymes
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amicus Therapeutics, Inc.
- National Drug Code (NDC)
- 71904-0200
More about Pombiliti (cipaglucosidase alfa)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: lysosomal enzymes
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.